Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TIM4 (T-cell Immunoglobulin and Mucin Domain Containing 4) is a cell surface receptor primarily known for its role in the immune system as a phosphatidylserine (PS) receptor. It is mainly expressed by antigen-presenting cells (APCs) like macrophages and dendritic cells. TIM4 recognizes PS exposed on apoptotic cell surfaces, mediating their engulfment by phagocytes, which is crucial for tissue homeostasis and preventing autoimmunity. It also modulates adaptive immunity and can be involved in allergic responses and tumor immunity. Ectopic expression has been observed in tumors and blockade is being explored as a therapeutic strategy.
Blockade of TIM4-phosphatidylserine interaction to enhance anti-tumor immunity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell Immunoglobulin and Mucin Domain Containing 4 (TIM4).